2015
DOI: 10.1515/jccm-2015-0022
|View full text |Cite
|
Sign up to set email alerts
|

An Evaluation of Serum Procalcitonin and C-Reactive Protein Levels as Diagnostic and Prognostic Biomarkers of Severe Sepsis

Abstract: The procalcitonin levels are highly correlated with the severity scores (APACHE II, SAPS II, SOFA) regularly used in ICUs and therefore can be used for determining the severity of the septic process. Quantitive procalcitonin and C-reactive protein analysis was not shown to be useful in diagnosing severe sepsis. However, PCT and CRP can be used to predict the fatal progression of the septic patient.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
16
0

Year Published

2016
2016
2022
2022

Publication Types

Select...
9
1

Relationship

1
9

Authors

Journals

citations
Cited by 19 publications
(16 citation statements)
references
References 24 publications
0
16
0
Order By: Relevance
“…Recently, multiple biomarkers have been studied. A study performed on septic patients underlined the fact that even though C-reactive protein and procalcitonin levels are not useful in diagnosing severe sepsis, they can be used in order to predict the fatal progression of this disorder [27]. Soluble urokinase-type plasminogen activator receptor (suPAR) is another important biomarker that seems have a predictive capacity for bacteremia in sepsis, even though it appears to be an independent factor for mortality prognosis in septic patients [28].…”
Section: Discussionmentioning
confidence: 99%
“…Recently, multiple biomarkers have been studied. A study performed on septic patients underlined the fact that even though C-reactive protein and procalcitonin levels are not useful in diagnosing severe sepsis, they can be used in order to predict the fatal progression of this disorder [27]. Soluble urokinase-type plasminogen activator receptor (suPAR) is another important biomarker that seems have a predictive capacity for bacteremia in sepsis, even though it appears to be an independent factor for mortality prognosis in septic patients [28].…”
Section: Discussionmentioning
confidence: 99%
“…In recent years, the idea of sepsis biomarkers which can aid early diagnosis and the susceptibility of individuals has been established. However, none has the specificity necessary for the exclusive use, and it is currently accepted that a diagnosis of sepsis requires the identification of serum BM panels [ 6 , 7 , 8 ].…”
Section: Introductionmentioning
confidence: 99%
“…PCT is released by the solid tissue cells of liver and peripheral blood mononuclear cellsduring microbial infection.But Liver failure may lead to the formation ofa network of monocytes to reduce theconcentration of acute-phase proteins (APPs) [32]. The more severe the underlying liver dysfunction, the lower the CRP response to bacteremia [33].JJanos Szederjesi et al reported there was no signi cant correlation between the levels of the PCT and CRP biomarkers and severe sepsis .Quantitive procalcitonin and C-reactive protein analysis was not shown to be useful in diagnosing severe sepsis [34].Our data showed that levels of CRP and PCT in liver cirrhosis patients with sepsis did not increase signi cantly (Table 2), even though they were signi cantly different between the non-sepsis group and sepsis group.…”
Section: Discussionmentioning
confidence: 99%